Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era Gizal Nakshbandi, Catharina C. Moor, Kerri A. Johannson, Toby M. Maher, Michael Kreuter, Marlies S. Wijsenbeek ERJ Open Res, 7 (3) 00405-2021; 10.1183/23120541.00405-2021 |    |
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study Joanna C. Porter, Thida Win, Kjell Erlandsson, Francesco Fraioli, Alaleh Rashidnasab, Beverley Holman, Balaji Ganeshan, Nicholas J. Screaton, Toby M. Maher, Raymond Endozo, John Hoath, Robert I. Shortman, Elise Emond, Kris Thielemans, Brian F. Hutton, Pauline T. Lukey, Franklin Aigbirhio, Saif Khan, Manuel Rodriguez-Justo, Ashley M. Groves Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020 |    |
COVID-19 pneumonia and the pulmonary vasculature: a marriage made in hell Peter M. George, Sujal R. Desai Eur Respir J, 58 (3) 2100811; 10.1183/13993003.00811-2021 |    |
Histopathology of newborn lung disease Michael T. Ashworth, J. Ciaran Hutchinson, Mohammad Haini Eur Respir Monogr 2021; 92: 287-300 |   |
Interstitial lung diseases in the neonatal period Yohan Soreze, Chiara Sileo, Aurore Coulomb l'Hermine, Marie Legendre, Nadia Nathan Eur Respir Monogr 2021; 92: 213-230 |   |
In utero and post-natal development of the human lung and its defence mechanisms Daniel T. Swarr, Hitesh Deshmukh, William Zacharias Eur Respir Monogr 2021; 92: 1-20 |   |
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema An Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, Mark G. Jones, Coline van Moorsel, Tamera J. Corte, Chiara Romei, Recep Savas, Christopher J. Brereton, Hendrik W. van Es, Helen Jo, Annalisa De Liperi, Omer Unat, Katarina Pontoppidan, Frouke van Beek, Marcel Veltkamp, Peter Hopkins, Yuben Moodley, Alessandro Taliani, Laura Tavanti, Bahareh Gholipour, Arjun Nair, Sam Janes, Iain Stewart, David Barber, Daniel C. Alexander, Athol U. Wells, Joseph Jacob ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021 |    |
Lung ultrasound assessment for pneumothorax following transbronchial lung cryobiopsy Christian B. Laursen, Pia I. Pietersen, Niels Jacobsen, Casper Falster, Amanda D. Juul, Jesper R. Davidsen ERJ Open Res, 7 (3) 00045-2021; 10.1183/23120541.00045-2021 |    |
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment Clara Hjalmarsson, Barbro Kjellström, Kjell Jansson, Magnus Nisell, David Kylhammar, Mohammad Kavianipour, Göran Rådegran, Stefan Söderberg, Gerhard Wikström, Dirk M. Wuttge, Roger Hesselstrand ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020 |    |
Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients Stine Johnsen, Stefan M. Sattler, Kamilla Woznica Miskowiak, Keerthana Kunalan, Alan Victor, Lars Pedersen, Helle Frost Andreassen, Barbara Jolanta Jørgensen, Hanne Heebøll, Michael Brun Andersen, Lisbeth Marner, Carsten Hædersdal, Henrik Hansen, Sisse Bolm Ditlev, Celeste Porsbjerg, Thérèse S. Lapperre ERJ Open Res, 7 (3) 00205-2021; 10.1183/23120541.00205-2021 |    |
Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis Osamu Nishiyama, Kensuke Kataoka, Masahiko Ando, Shinichi Arizono, Akira Morino, Koichi Nishimura, Tomoya Ogawa, Akira Shiraki, Fumiko Watanabe, Ryo Kozu, Takashi Ogura, Yasuhiro Kondoh ERJ Open Res, 7 (3) 00321-2021; 10.1183/23120541.00321-2021 |    |
Risk factors associated with the development of interstitial lung abnormalities Ivette Buendía-Roldán, Rosario Fernandez, Mayra Mejía, Fortunato Juarez, Gustavo Ramirez-Martinez, Eduardo Montes, Ana Karem S. Pruneda, Karen Martinez-Espinosa, Aime Alarcon-Dionet, Iliana Herrera, Carina Becerril, Leslie Chavez-Galan, Mario Preciado, Annie Pardo, Moisés Selman Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020 |    |
ERS guidelines on treatment of sarcoidosis D. Valeyre (Paris, France), Robert P. Baughman (Cincinnati, USA), P. Korsten (Göttingen, Germany)
Wednesday, 23 June 2021 |   |
Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD E. Bargagli, (Siena, Italy), E. Renzoni (London, United Kingdom), O. Distler (Zurich, Switzerland), K. Antoniou (Heraklion, Greece), B. Crestani (Paris, France)
Monday, 14 June 2021 |   |
Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Manuela Platé, Yoshihiko Kobayashi, Rachel C. Chambers, Purushothama Rao Tata Eur Respir Monogr 2021; 91: 290-305 |   |
Evidence for the involvement of lipofibroblasts, airway smooth muscle cells and FGF10 signalling in lung repair Elie El Agha, Saverio Bellusci Eur Respir Monogr 2021; 91: 99-113 |   |
Natural variability in the disease course of SSc-ILD: implications for treatment Madelon C. Vonk, Ulrich A. Walker, Elizabeth R. Volkmann, Michael Kreuter, Sindhu R. Johnson, Yannick Allanore Eur Respir Rev, 30 (159) 200340; 10.1183/16000617.0340-2020 |    |
Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study Sebastian Majewski, Xingwu Zhou, Joanna Milkowska-Dymanowska, Adam J. Bialas, Wojciech J. Piotrowski, Andrei Malinovschi ERJ Open Res, 7 (1) 00489-2020; 10.1183/23120541.00489-2020 |    |
Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis Sang-Hun Kim, Jung Yeon Lee, Chang Min Yoon, Hyeon Jun Shin, Sei Won Lee, Ivan Rosas, Erica Herzog, Charles S. Dela Cruz, Naftali Kaminski, Min-Jong Kang Eur Respir J, 57 (4) 2000652; 10.1183/13993003.00652-2020 |    |
Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort Raphael Lhote, Isabella Annesi-Maesano, Hilario Nunes, David Launay, Raphael Borie, Karim Sacré, Nicolas Schleinitz, Mohamed Hamidou, Matthieu Mahevas, Hervé Devilliers, Philippe Bonniaud, François Lhote, Julien Haroche, Pierre Rufat, Zahir Amoura, Dominique Valeyre, Fleur Cohen Aubart Eur Respir J, 57 (4) 2001160; 10.1183/13993003.01160-2020 |    |
MAV(S)erick mitochondria: an unconventional role for mitochondrial antiviral signalling protein in pulmonary fibrosis Ram P. Naikawadi, Paul J. Wolters Eur Respir J, 57 (4) 2004500; 10.1183/13993003.04500-2020 |    |
Reply: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Jürgen Behr, David Pittrow, Jens Klotsche Eur Respir J, 57 (3) 2100283; 10.1183/13993003.00283-2021 |    |
Comment on: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Jakob Borchardt Eur Respir J, 57 (3) 2004645; 10.1183/13993003.04645-2020 |    |
Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias? Samy Suissa, Deborah Assayag Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020 |    |
Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study Amir M. Hasani, Brianna Matthew, Mahshid Goljamali, Yun-Ching Chen, Mario Stylianou, Mehdi Pirooznia, Angelo Taveira-DaSilva, Marcus Y. Chen, Han Wen, Joel Moss Eur Respir J, 57 (3) 2003769; 10.1183/13993003.03769-2020 |    |
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation Spyros A. Papiris, Demosthenes Bouros, Katerina Markopoulou, Lykourgos Kolilekas, Andriana I. Papaioannou, Vasilios Tzilas, Argyrios Tzouvelekis, Eva Fouka, Despoina Papakosta, Zoe Daniil, Paschalis Steiropoulos, Athina Gogali, Ilias C. Papanikolaou, Areti Xyfteri, Aggeliki Haritou, Ioanna Korbila, Ioannis P. Tomos, Stylianos Loukides, Rita Bellelli, Georgia Kounti, Christina Rampiadou, Theodoros Karampitsakos, Ilias Dimeas, Paraskevi Kirgou, Andromachi Bompoki, Eirini Vasarmidi, Konstantinos Loverdos, Elvira-Markela Antonogiannaki, Myrto Blizou, Evangelos Bouros, Konstantinos Kagouridis, Maria Maniati, Anna Karakatsani, Katerina M. Antoniou, Effrosyni D. Manali Eur Respir J, 57 (3) 2003111; 10.1183/13993003.03111-2020 |    |
PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Joan Truyols, Spain
|  |
PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Lea de Maddalena, Switzerland
|  |
PP215 – The effect of long-term personal air pollution exposure on the inflammatory mediators in Idiopathic Pulmonary Fibrosis Ioannis Tomos, Greece
|  |
PP212 – The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages Carolin Koss, Germany
|  |
PP208 – SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis Carmen Veith, Germany
|  |
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Victoria Ptasinski, Sweden
|  |
PP121 – Gaq/11 and Ga12/13 promote pulmonary fibrosis by driving distinct myofibroblast functions Amanda Goodwin, United Kingdom
|  |
Genetic disorders of the surfactant system: focus on adult disease Coline H.M. van Moorsel, Joanne J. van der Vis, Jan C. Grutters Eur Respir Rev, 30 (159) 200085; 10.1183/16000617.0085-2020 |    |
“Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study” Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu and Demosthenes Bouros. ERJ Open Res 2020; 6: 00152-2020.
ERJ Open Res, 7 (1) 50152-2020; 10.1183/23120541.50152-2020 |   |
Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect Teng Moua, Aahd Kubbara, Paul Novotny, Jennifer L. Ridgeway, Andrew H. Limper, Jay H. Ryu, Matthew M. Clark, Roberto Benzo ERJ Open Res, 7 (1) 00011-2021; 10.1183/23120541.00011-2021 |    |
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease Michael P. Mohning, Isabelle Amigues, M. Kristen Demoruelle, Evans R. Fernández Pérez, Tristan J. Huie, Rebecca K. Keith, Amy L. Olson, Zulma X. Yunt, Jonathan H. Chung, Stephen Hobbs, Jeffrey J. Swigris, Joshua J. Solomon ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020 |    |
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi ERJ Open Res, 7 (1) 00196-2020; 10.1183/23120541.00196-2020 |    |
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review Anna-Maria Hoffmann-Vold, Toby M. Maher, Edward E. Philpot, Ali Ashrafzadeh, Oliver Distler ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020 |    |
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis Ayodeji Adegunsoye, Julie Morisset, Chad A. Newton, Justin M. Oldham, Eric Vittinghoff, Angela L. Linderholm, Mary E. Strek, Imre Noth, Christine Kim Garcia, Paul J. Wolters, Brett Ley Eur Respir J, 57 (3) 2002872; 10.1183/13993003.02872-2020 |    |
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, Melanie Dohmen, Markus C. Brack, Sabrina Schulz, Elisa Thomasch, Szandor Simmons, Holger Müller-Redetzky, Norbert Suttorp, Florian Kurth, Jens Neudecker, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Victor Max Corman, Andreas C. Hocke, Martin Witzenrath, Stefan Hippenstiel, Wolfgang M. Kuebler Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020 |    |
Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-? Liv I.B. Sikkeland, Shuo-Wang Qiao, Thor Ueland, Ole Myrdal, Lukasz Wyrozemski, Pål Aukrust, Frode L. Jahnsen, Tone Sjåheim, Johny Kongerud, Øyvind Molberg, May Brit Lund, Espen S. Bækkevold Eur Respir J, 57 (3) 2000983; 10.1183/13993003.00983-2020 |    |
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1 Yoshinari Nakatsuka, Ai Yaku, Tomohiro Handa, Alexis Vandenbon, Yuki Hikichi, Yasutaka Motomura, Ayuko Sato, Masanori Yoshinaga, Kiminobu Tanizawa, Kizuku Watanabe, Toyohiro Hirai, Kazuo Chin, Yutaka Suzuki, Takuya Uehata, Takashi Mino, Tohru Tsujimura, Kazuyo Moro, Osamu Takeuchi Eur Respir J, 57 (3) 2000018; 10.1183/13993003.00018-2020 |    |
The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis Maria-Pia Di Campli, Abdulkader Azouz, Assiya Assabban, Jessika Scaillet, Marion Splittgerber, Alexandra Van Keymeulen, Frederick Libert, Myriam Remmelink, Alain Le Moine, Philippe Lemaitre, Stanislas Goriely Eur Respir J, 57 (3) 2000344; 10.1183/13993003.00344-2020 |    |
Regulation of immune cells in lung fibrosis: the reign of regnase-1? Antoine Froidure, Bruno Crestani Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020 |    |
Reply: BAL lymphocyte percentage is as good as the company it keeps Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021 |    |
Comment on: Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis Onofre Moran-Mendoza, Mohamed Khalil Eur Respir J, 57 (2) 2004347; 10.1183/13993003.04347-2020 |    |
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation Aurélien Justet, Dymph Klay, Raphaël Porcher, Vincent Cottin, Kais Ahmad, Maria Molina Molina, Hilario Nunes, Martine Reynaud-Gaubert, Jean Marc Naccache, Effrosyni Manali, Antoine Froidure, Stéphane Jouneau, Lidwine Wemeau, Claire Andrejak, Anne Gondouin, Sandrine Hirschi, Elodie Blanchard, Benjamin Bondue, Philippe Bonniaud, Cécile Tromeur, Grégoire Prévot, Sylvain Marchand-Adam, Manuela Funke-Chambour, Anne Sophie Gamez, Ibrahima Ba, Spyridon Papiris, Jan Grutters, Bruno Crestani, Coline van Moorsel, Caroline Kannengiesser, Raphaël Borie Eur Respir J, 57 (2) 2003198; 10.1183/13993003.03198-2020 |    |
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study) Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, Kaïs Ahmad, Loic Boussel, Marie Brevet, Lara Chalabreysse, Céline Fabre, Sébastien Marque, Didier Revel, Françoise Thivolet-Bejui, Julie Traclet, Sabrina Zeghmar, Delphine Maucort-Boulch, Vincent Cottin Eur Respir J, 57 (2) 2002718; 10.1183/13993003.02718-2020 |    |
Methotrexate and rheumatoid arthritis associated interstitial lung disease Pierre-Antoine Juge, Joyce S. Lee, Jessica Lau, Leticia Kawano-Dourado, Jorge Rojas Serrano, Marco Sebastiani, Gouri Koduri, Eric Matteson, Karina Bonfiglioli, Marcio Sawamura, Ronaldo Kairalla, Lorenzo Cavagna, Emanuele Bozzalla Cassione, Andreina Manfredi, Mayra Mejia, Pedro Rodríguez-Henriquez, Montserrat I. González-Pérez, Ramcés Falfán-Valencia, Ivette Buendia-Roldán, Gloria Pérez-Rubio, Esther Ebstein, Steven Gazal, Raphaël Borie, Sébastien Ottaviani, Caroline Kannengiesser, Benoît Wallaert, Yurdagul Uzunhan, Hilario Nunes, Dominique Valeyre, Nathalie Saidenberg-Kermanac'h, Marie-Christophe Boissier, Lidwine Wemeau-Stervinou, René-Marc Flipo, Sylvain Marchand-Adam, Pascal Richette, Yannick Allanore, Claire Dromer, Marie-Elise Truchetet, Christophe Richez, Thierry Schaeverbeke, Huguette Lioté, Gabriel Thabut, Kevin D. Deane, Joshua J. Solomon, Tracy Doyle, Jay H. Ryu, Ivan Rosas, V. Michael Holers, Catherine Boileau, Marie-Pierre Debray, Raphaël Porcher, David A. Schwartz, Robert Vassallo, Bruno Crestani, Philippe Dieudé Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020 |    |
The case of methotrexate and the lung: Dr Jekyll and Mr Hyde Vincent Cottin, Elizabeth Bendstrup, Philippe Bonniaud, Mouhamad Nasser, Paolo Spagnolo, Claudia Valenzuela, Martin Kolb Eur Respir J, 57 (2) 2100079; 10.1183/13993003.00079-2021 |    |
The cardiovascular system in idiopathic pulmonary fibrosis Sy Giin Chong, Toyoshi Yanagihara, Martin R.J. Kolb Eur Respir Monogr 2020; 88: 198-211 |   |
Patients living with other respiratory diseases Arwel W. Jones, Rachel E. Gemine, Syedah Aleena Haider Eur Respir Monogr 2021; 90: 193-207 |   |
Interstitial lung disease in welders Martin Paul Cosgrove Eur Respir Monogr 2020; 89: 238-251 |   |
Pneumoconiosis and interstitial lung diseases caused by inorganic dust Jennifer Louise Hoyle Eur Respir Monogr 2020; 89: 190-210 |   |
Coal mine dust lung disease Leonard H.T. Go, Robert A. Cohen Eur Respir Monogr 2020; 89: 176-189 |   |
Silicosis and other silica-related lung disorders Deborah Helwen Yates, Anthony Rutledge Johnson Eur Respir Monogr 2020; 89: 150-175 |   |
Asbestosis Kirsten Bennett, Fraser J.H. Brims Eur Respir Monogr 2020; 89: 125-139 |   |
Occupational hypersensitivity pneumonitis Christopher Michael Barber, Hayley Barnes Eur Respir Monogr 2020; 89: 104-124 |   |
Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis Sabrina Bajwah, Jill Colquitt, Emma Loveman, Claudia Bausewein, Howard Almond, Adejoke Oluyase, Mendy Dzingina, Matthew Maddocks, Irene J. Higginson, Athol Wells ERJ Open Res, 7 (1) 00107-2020; 10.1183/23120541.00107-2020 |    |
Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019 Lisa G. Spencer, Maria Loughenbury, Nazia Chaudhuri, Monica Spiteri, Helen Parfrey ERJ Open Res, 7 (1) 00187-2020; 10.1183/23120541.00187-2020 |    |
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus Argyris Tzouvelekis, Katerina Antoniou, Michael Kreuter, Matthew Evison, Torsten G. Blum, Venerino Poletti, Bogdan Grigoriu, Carlo Vancheri, Paolo Spagnolo, Theodoros Karampitsakos, Francesco Bonella, Athol Wells, Ganesh Raghu, Maria Molina-Molina, Daniel A. Culver, Elisabeth Bendstrup, Nesrin Mogulkoc, Stefano Elia, Jacques Cadranel, Demosthenes Bouros ERJ Open Res, 7 (1) 00529-2020; 10.1183/23120541.00529-2020 |    |
Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact Yuji Yamamoto, Kazuyuki Tsujino, Tomoki Kuge, Fukuko Okabe, Takahiro Kawasaki, Takanori Matsuki, Hiroyuki Kagawa, Mari Miki, Keisuke Miki, Masahide Mori, Hiroshi Kida ERJ Open Res, 7 (1) 00765-2020; 10.1183/23120541.00765-2020 |    |
Chronic lung diseases: prospects for regeneration and repair Peter J. Barnes, Gary P. Anderson, Malin Fagerås, Maria G. Belvisi Eur Respir Rev, 30 (159) 200213; 10.1183/16000617.0213-2020 |    |
Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients David G. Chapman, Tanya Badal, Gregory G. King, Cindy Thamrin Eur Respir J, 57 (1) 2003263; 10.1183/13993003.03263-2020 |    |
Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new Paolo Maria Leone, Luca Richeldi Breathe, 16 (4) 200223; 10.1183/20734735.0223-2020 |    |
Pulmonary alveolar microlithiasis Patrick Kosciuk, Cristopher Meyer, Kathryn A. Wikenheiser-Brokamp, Francis X. McCormack Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020 |    |
Lung involvement in monogenic interferonopathies Salvatore Cazzato, Alessia Omenetti, Claudia Ravaglia, Venerino Poletti Eur Respir Rev, 29 (158) 200001; 10.1183/16000617.0001-2020 |    |
Alveolar proteinosis of genetic origins Alice Hadchouel, David Drummond, Rola Abou Taam, Muriel Lebourgeois, Christophe Delacourt, Jacques de Blic Eur Respir Rev, 29 (158) 190187; 10.1183/16000617.0187-2019 |    |
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis Ingrid A. Cox, Nicolas Borchers Arriagada, Barbara de Graaff, Tamera J. Corte, Ian Glaspole, Stella Lartey, E. Haydn Walters, Andrew J. Palmer Eur Respir Rev, 29 (158) 200154; 10.1183/16000617.0154-2020 |    |
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis Antoine Froidure, Emmeline Marchal-Duval, Meline Homps-Legrand, Mada Ghanem, Aurélien Justet, Bruno Crestani, Arnaud Mailleux Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019 |    |
“Desquamative interstitial pneumonia: a systematic review of its features and outcomes.” Merel E. Hellemons, Catharina C. Moor, Jan von der Thüsen, Mariska Rossius, Arlette Odink, Laila Haugen Thorgersen, Johny Verschakelen, Wim Wuyts, Marlies S. Wijsenbeek and Elisabeth Bendstrup. Eur Respir Rev 2020; 29: 190181.
Eur Respir Rev, 29 (157) 190181; 10.1183/16000617.5181-2019 |   |
Birt–Hogg–Dubé syndrome Cécile Daccord, Jean-Marc Good, Marie-Anne Morren, Olivier Bonny, Daniel Hohl, Romain Lazor Eur Respir Rev, 29 (157) 200042; 10.1183/16000617.0042-2020 |    |
Ultra-rare cystic disease Davide Elia, Olga Torre, Roberto Cassandro, Antonella Caminati, Sergio Harari Eur Respir Rev, 29 (157) 190163; 10.1183/16000617.0163-2019 |    |
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review Yet H. Khor, Yvonne Ng, Hayley Barnes, Nicole S.L. Goh, Christine F. McDonald, Anne E. Holland Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019 |    |
Fibrotic interstitial lung diseases and air pollution: a systematic literature review Sergio Harari, Ganesh Raghu, Antonella Caminati, Mario Cruciani, Massimo Franchini, Piermannuccio Mannucci Eur Respir Rev, 29 (157) 200093; 10.1183/16000617.0093-2020 |    |
Lung complications of Sjogren syndrome Fabrizio Luppi, Marco Sebastiani, Nicola Sverzellati, Alberto Cavazza, Carlo Salvarani, Andreina Manfredi Eur Respir Rev, 29 (157) 200021; 10.1183/16000617.0021-2020 |    |
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis Manuela Platé, Delphine Guillotin, Rachel C Chambers Eur Respir Rev, 29 (157) 200269; 10.1183/16000617.0269-2020 |    |
Familial hypersensitivity pneumonitis triggered by Cladosporium herbarum exposure during carpooling Thomas Planté-Bordeneuve, Olivier Gilbert, Dominique Latinne, Nicolas Bruffaerts, Benoit Ghaye, Antoine Froidure ERJ Open Res, 6 (3) 00233-2020; 10.1183/23120541.00233-2020 |    |
Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial Tessa Schneeberger, Daniela Leitl, Rainer Gloeckl, Inga Jarosch, Daniela Reimann, Wolfgang Hitzl, Rembert Koczulla, Klaus Kenn ERJ Open Res, 6 (3) 00197-2020; 10.1183/23120541.00197-2020 |    |
No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis Quentin Le Hingrat, Mada Ghanem, Aurélie Cazes, Benoit Visseaux, Gilles Collin, Diane Descamps, Charlotte Charpentier, Bruno Crestani ERJ Open Res, 6 (3) 00243-2020; 10.1183/23120541.00243-2020 |    |
Transbronchial cryobiopsy: an effective tool in the diagnosis of lymphoproliferative disorders of the lung Rita Bianchi, Alessandra Dubini, Silvia Asioli, Claudia Ravaglia, Sara Tomassetti, Silvia Puglisi, Sara Piciucchi, Christian Gurioli, Carlo Gurioli, Roberto Fiocca, Venerino Poletti ERJ Open Res, 6 (3) 00260-2019; 10.1183/23120541.00260-2019 |    |
Amyloidosis of the respiratory system: 16 patients with amyloidosis initially diagnosed ante mortem by pulmonologists Masami Yamada, Noboru Takayanagi, Hideaki Yamakawa, Takashi Ishiguro, Tomohisa Baba, Yoshihiko Shimizu, Koji Okudela, Tamiko Takemura, Takashi Ogura ERJ Open Res, 6 (3) 00313-2019; 10.1183/23120541.00313-2019 |    |
Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire Tananchai Petnak, Teng Moua ERJ Open Res, 6 (3) 00230-2020; 10.1183/23120541.00230-2020 |    |
Pulmonary alveolar microlithiasis: no longer in the stone age Elisabeth Bendstrup, Åsa Lina M. Jönsson ERJ Open Res, 6 (3) 00289-2020; 10.1183/23120541.00289-2020 |    |
The association of pulmonary fibrosis with diabetes mellitus Niranjan Jeganathan, Christelle Miot, Airani Sathananthan, Matheni Sathananthan ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 |    |
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis Faria Nasim, Teng Moua ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020 |    |
Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study Mukunthan Murthi, Keiichiro Yoshioka, Jeong Hee Cho, Sixto Arias, Elio Danna, Moe Zaw, Greg Holt, Koichiro Tatsumi, Takeshi Kawasaki, Mehdi Mirsaeidi ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020 |    |
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease John Odackal, Victor Yu, Diana Gomez-Manjerres, Joshua J. Field, Marie D. Burdick, Borna Mehrad ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020 |    |
Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis Jesper Rømhild Davidsen, Lars Christian Lund, Christian B. Laursen, Jesper Hallas, Daniel Pilsgaard Henriksen ERJ Open Res, 6 (4) 00479-2020; 10.1183/23120541.00479-2020 |    |
Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros ERJ Open Res, 6 (4) 00152-2020; 10.1183/23120541.00152-2020 |    |
Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis Severi Seppälä, Kaisa Rajala, Juho Tuomas Lehto, Eva Sutinen, Laura Mäkitalo, Hannu Kautiainen, Hannu Kankaanranta, Mari Ainola, Tiina Saarto, Marjukka Myllärniemi ERJ Open Res, 6 (4) 00347-2020; 10.1183/23120541.00347-2020 |    |
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Yaniv Dotan, William B. Shapiro, Eneida Male, Eduardo C. Dominguez, Amandeep Aneja, Zhao Huaqing, Chandra Dass, Kartik Shenoy, Nathaniel Marchetti, Francis C. Cordova, Gerard J. Criner, A. James Mamary ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019 |    |
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly Sheila Ramjug, Jason Weatherald, Sandeep Sahay, Johad Khoury, Vasile Foris, Nagaraj Chandran, Aleksandar Bokan, Laurent Godinas, Marion Delcroix ERJ Open Res, 6 (4) 00304-2020; 10.1183/23120541.00304-2020 |    |
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly Clairelyne Dupin, Vânia Fernandes, Fernanda Hernandez-Gonzalez, Sebastiano Emanuele Torrisi, Tiago M. Alfaro, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti ERJ Open Res, 6 (4) 00143-2020; 10.1183/23120541.00143-2020 |    |
The adoption of nintedanib in systemic sclerosis: the SENSCIS study Teresa Bruni, Francesco Varone Breathe, 16 (2) 200005; 10.1183/20734735.0005-2020 |    |
Pulmonary alveolar proteinosis: from classification to therapy Elena Salvaterra, Ilaria Campo Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 |    |
Lymphangioleiomyomatosis: a clinical review Anne M. O'Mahony, Evelyn Lynn, David J. Murphy, Aurelie Fabre, Cormac McCarthy Breathe, 16 (2) 200007; 10.1183/20734735.0007-2020 |    |
Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need Amanda T. Goodwin, Gauri Saini Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020 |    |
Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples Andrea Crespo, Tiago Alfaro, Vivien Somogyi, Michael Kreuter Breathe, 16 (3) 200067; 10.1183/20734735.0067-2020 |    |